About
What this site is for and who publishes it.
Released: · Last reviewed:
Tirzepatide Telehealth Comparison puts tirzepatide telehealth programs side by side: what each charges all-in at a maintenance dose, what it bundles or bills separately, which pharmacy fills the prescription, and what happens if you stop.
What we publish
Program reviews, head-to-head comparisons, best-of lists filtered on one criterion, state pages, an open dataset and short dated answers. Prices are read on each program’s own pages; this edition’s reads are dated October 15, 2026, with NexLife’s prices as of November 6, 2026.
Who is behind it
Research by Dr. Parmis; medical review by Dr. Jonathan Snipes, MD and Kim Callender, NP (FNP-BC). See the team page.
How it is funded
Tirzepatide Telehealth Comparison is affiliate-supported and may earn a commission when readers enroll through links on this site. Compensation never changes our methodology, rankings or the prices we report. See the affiliate disclosure and ownership pages.
Released and reviewed
The site was released on August 7, 2026. This edition was reviewed on November 10, 2026.